Home
Incepta Vaccine

Incepta Vaccine Market Share Analysis for July 2026

Health > Pharmacy

Domaininceptavaccine.com

Year Founded1999

Employees1001 - 5000

Annual Revenue$50M - $75M

Incepta Vaccine

Incepta Vaccine (including company regionals)

inceptavaccine.com

See more website traffic and engagement information

Incepta Vaccine Revenue up to July 2026 is 50M - 75M

revenue generated by Incepta Vaccine top domains

Incepta Vaccine top domains revenue over 3 years

Revenue for Incepta Vaccine top domains

inceptavaccine.com50M - 75M

See more with Sales Intelligence

Total visits to Incepta Vaccine's top domains

Understand Incepta Vaccine market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

inceptavaccine.com17.8K

See more with Sales Intelligence

Avg. visit duration in Incepta Vaccine's top domains

Analyze Incepta Vaccine engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

inceptavaccine.com00:01:56

See more with Sales Intelligence

Avg. pageviews on Incepta Vaccine's top domains

See how Incepta Vaccine keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

inceptavaccine.com2.32

See more with Sales Intelligence

Incepta Vaccine top competitors by domain

Top similar sites in July 2026, ranked by their affinity

inceptapharma.comCompany NameIncepta PharmaceuticalsEmployees5001 - 10000HQBangladesh, dhakaAnnual revenue$200M - $500MTotal visits53.3KHealth > Pharmacy

Top technologies used by Incepta Vaccine

These are the website technologies, by industry, used by Incepta Vaccine top domains

Advertising (15)

PubMatic

Conversion & Analytics (5)

Google Analytics

Widget (3)

reCAPTCHA

Content Management System (2)

WordPress

More Technologies

8

See all

News & Signals from Incepta Vaccine

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsIncepta Vaccine Ltd. launches two biosimilar biologics.He said Incepta launched two biosimilar biologics with its own API, one of which is a cervical cancer vaccine aiming to make Bangladesh a cervical cancer-free nation in 2022 and the other is a pneumococcal vaccine, a life-saving product that was scarce in the market previously in 2023.

NewsIncepta Vaccine Ltd. launches pneumococcal vaccine.In 2023, Incepta launched pneumococcal vaccine which is a life-saving product that was scarce in the market previously.

NewsIncepta Vaccine Ltd. launches Papilovax.The vaccine is currently too expensive for the poor, they said, speaking at a seminar on cervical cancer on Tuesday at the Pan Pacific Sonargaon Hotel, where Incepta Vaccine officially launched Papilovax.